Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 16, 2016
Drug Name |
Review Type |
Class |
Manufacturer |
|
Prezcobix
|
New Drug Initial Review
|
HIV
|
Johnson & Johnson
|
|
Envarsus XR
|
New Drug Initial Review
|
Immunosupressant
|
Veloxis Pharmaceuticals
|
|
Nucala
|
New Drug Initial Review
|
Severe Asthma
|
Glaxo Smith Kline
|
|
Zomacton
|
New Drug Initial Review
|
Growth Hormone
|
Ferring Pharmaceuticals
|
|
Veltassa
|
New Drug Initial Review
|
Potassium Binder
|
Relypsa, Inc.
|
|
Zepatier
|
New Drug initial Review
|
Hepatitis C
|
Merck
|
|
Jadenu
|
New Drug Appeal
|
Iron Chelator
|
Novartis
|
|
Triumeq
|
New Drug Appeal
|
HIV
|
ViiV Healthcare
|
|
Kitabis
|
New Drug Appeal
|
Cystic Fibrosis
|
Pari Respiratory, Inc.
|
|
Invega Trinza
|
New Drug Appeal
|
Long Acting Antipsychotic
|
Johnson & Johnson
|